Product Code: ETC13245688 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Artificial Intelligence In Drug Discovery Market was valued at USD 2.7 Billion in 2024 and is expected to reach USD 9.2 Billion by 2031, growing at a compound annual growth rate of 17.03% during the forecast period (2025-2031).
The Global Artificial Intelligence in Drug Discovery Market is witnessing significant growth driven by the increasing need for efficient drug development processes and the rising adoption of AI technologies in the healthcare sector. AI is being utilized to accelerate the drug discovery process by analyzing vast amounts of data, predicting drug-target interactions, and identifying potential drug candidates. The market is characterized by the presence of key players offering AI solutions for drug discovery, collaborations between pharmaceutical companies and AI technology providers, and a growing emphasis on precision medicine. Factors such as the increasing prevalence of chronic diseases, the growing demand for personalized medicines, and the advancements in AI algorithms are expected to further propel the market growth. North America currently dominates the market, followed by Europe and Asia-Pacific regions.
The Global Artificial Intelligence in Drug Discovery Market is experiencing significant growth due to the increasing demand for innovative solutions to accelerate drug development processes. Key trends in the market include the adoption of machine learning, deep learning, and other AI technologies to identify potential drug candidates, predict drug-target interactions, and optimize drug designs. Opportunities in the market lie in the development of personalized medicine, precision drug targeting, and the utilization of AI for repurposing existing drugs. The market is also witnessing partnerships between pharmaceutical companies and AI technology providers to enhance drug discovery capabilities. Overall, the Global AI in Drug Discovery Market is poised for continued expansion as advancements in AI algorithms and technologies revolutionize the pharmaceutical industry.
The Global Artificial Intelligence in Drug Discovery market faces several challenges, including the complexity of biological systems, the need for large and high-quality datasets, regulatory hurdles, and the interpretability of AI-driven results. Biological systems are intricate and dynamic, making it difficult to accurately model and predict drug interactions. Additionally, acquiring and maintaining comprehensive datasets for training AI models can be costly and time-consuming. Regulatory bodies also pose a challenge as they require transparency and validation of AI algorithms used in drug discovery. Finally, the interpretability of AI-generated results is crucial for gaining trust and acceptance in the pharmaceutical industry, as understanding the rationale behind AI-generated predictions is essential for decision-making. Overcoming these challenges will be crucial for unlocking the full potential of AI in revolutionizing drug discovery processes.
The Global Artificial Intelligence in Drug Discovery Market is primarily driven by the increasing demand for novel and more effective drugs, as well as the growing need to reduce the time and cost involved in the drug discovery process. Artificial intelligence technologies offer advanced data analytics, predictive modeling, and virtual screening capabilities, enabling pharmaceutical companies to accelerate the identification of potential drug candidates and streamline the overall drug development process. Additionally, the rising prevalence of chronic diseases, coupled with the expanding research and development activities in the pharmaceutical industry, further fuels the adoption of artificial intelligence in drug discovery. Integration of AI technologies such as machine learning and natural language processing into drug discovery processes is expected to revolutionize the industry by enhancing efficiency, accuracy, and success rates in drug development.
Government policies related to the Global Artificial Intelligence in Drug Discovery Market vary by country but generally focus on promoting innovation, ensuring patient safety, and streamlining regulatory processes. In the United States, the FDA has issued guidance on the use of AI and machine learning in drug development to ensure transparency and reproducibility. In the European Union, the European Medicines Agency has established a framework for assessing AI-based technologies in drug discovery. In China, the government has launched initiatives to promote the development of AI in healthcare, including drug discovery. Overall, governments are recognizing the potential of AI to revolutionize drug discovery and are working to create a supportive regulatory environment that encourages investment and growth in this rapidly expanding market.
The Global Artificial Intelligence in Drug Discovery Market is expected to witness significant growth in the coming years, driven by the increasing adoption of AI technologies to improve the efficiency and effectiveness of drug discovery processes. AI offers the potential to accelerate drug discovery timelines, reduce costs, and improve the success rate of drug development. The market is likely to be fueled by the growing need for innovative therapies, personalized medicine, and the continuous advancements in AI algorithms and technology. Key players in the pharmaceutical industry are increasingly investing in AI-driven drug discovery platforms and partnerships, further driving market growth. However, challenges related to data quality, regulatory concerns, and the need for skilled professionals may pose some obstacles to market expansion. Overall, the Global Artificial Intelligence in Drug Discovery Market is poised for robust growth in the foreseeable future.
In the Global Artificial Intelligence in Drug Discovery market, Asia is experiencing rapid growth due to increasing investments in AI technologies by pharmaceutical companies and research institutions. North America remains a key player, with a high adoption rate of AI in drug discovery processes and a strong focus on innovation. Europe is also a significant market, driven by collaborations between AI companies and pharmaceutical giants. The Middle East and Africa are showing promising growth potential, with a rising interest in leveraging AI for drug development. Latin America is witnessing a gradual uptake of AI in drug discovery, supported by government initiatives to promote technological advancements in the healthcare sector. Overall, these regions are contributing to the expansion of the global AI in drug discovery market through various partnerships, investments, and technological advancements.
Global Artificial Intelligence In Drug Discovery Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Artificial Intelligence In Drug Discovery Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Global Artificial Intelligence In Drug Discovery Market - Industry Life Cycle |
3.4 Global Artificial Intelligence In Drug Discovery Market - Porter's Five Forces |
3.5 Global Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Global Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.8 Global Artificial Intelligence In Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F |
4 Global Artificial Intelligence In Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Artificial Intelligence In Drug Discovery Market Trends |
6 Global Artificial Intelligence In Drug Discovery Market, 2021 - 2031 |
6.1 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Drug Optimization and Repurposing, 2021 - 2031 |
6.1.3 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Preclinical Testing, 2021 - 2031 |
6.1.4 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031 |
6.2.4 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.2.5 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Metabolic DiseasesInfectious Diseases, 2021 - 2031 |
6.2.6 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Software, 2021 - 2031 |
6.3.3 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Hardware, 2021 - 2031 |
6.3.4 Global Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Services, 2021 - 2031 |
7 North America Artificial Intelligence In Drug Discovery Market, Overview & Analysis |
7.1 North America Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 - 2031 |
7.2 North America Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.5 North America Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
8 Latin America (LATAM) Artificial Intelligence In Drug Discovery Market, Overview & Analysis |
8.1 Latin America (LATAM) Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
8.4 Latin America (LATAM) Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
8.5 Latin America (LATAM) Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
9 Asia Artificial Intelligence In Drug Discovery Market, Overview & Analysis |
9.1 Asia Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
9.4 Asia Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
9.5 Asia Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
10 Africa Artificial Intelligence In Drug Discovery Market, Overview & Analysis |
10.1 Africa Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
10.4 Africa Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
10.5 Africa Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
11 Europe Artificial Intelligence In Drug Discovery Market, Overview & Analysis |
11.1 Europe Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
11.4 Europe Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
11.5 Europe Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
12 Middle East Artificial Intelligence In Drug Discovery Market, Overview & Analysis |
12.1 Middle East Artificial Intelligence In Drug Discovery Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Artificial Intelligence In Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
12.4 Middle East Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
12.5 Middle East Artificial Intelligence In Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
13 Global Artificial Intelligence In Drug Discovery Market Key Performance Indicators |
14 Global Artificial Intelligence In Drug Discovery Market - Export/Import By Countries Assessment |
15 Global Artificial Intelligence In Drug Discovery Market - Opportunity Assessment |
15.1 Global Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
15.3 Global Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
15.4 Global Artificial Intelligence In Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F |
16 Global Artificial Intelligence In Drug Discovery Market - Competitive Landscape |
16.1 Global Artificial Intelligence In Drug Discovery Market Revenue Share, By Companies, 2024 |
16.2 Global Artificial Intelligence In Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |